SEC Form 4/A · accession 0001385508-19-000020
OPIANT PHARMACEUTICALS, INC. · OPNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Michael Sinclair
Director · 10% Owner
Period of report
Jan 17, 2017
Accepted (ET)
Mar 6, 2019 · 5:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001385508
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | holding | — | — | — | 30,000 | I | Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were omitted from the Reporting Person's original Form 3 and were also omitted from all Forms 4 filed by the reporting Person after his original Form 3 was filed.
- F2These shares are held by Sinclair Montrose Trust Ltd, of which the Reporting Person's spouse and adult children are the shareholders.